Skip to main content
    E

    Estrella Immunopharma Inc. (ESLA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.38
    -0.13 (-26.07%)

    Market Cap: $22.36M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Estrella Immunopharma Inc. (ESLA) Earnings: Report Dates and Results

    Updated Nov 13, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Estrella Immunopharma (ESLA) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, Estrella Immunopharma reported EPS of -$0.17, below the -$0.08 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    67%(6/9)
    Avg Surprise
    +14.01%

    Upcoming Estimates

    Reports Mar 16, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.07
    Range-$0.07 - -$0.07
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    ESLA has an expected report date of Mar 16, 2027.

    Earnings History

    Of the 9 quarters below that had an estimate, ESLA beat 6 and missed 3. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 112.50% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.17-$0.08-$0.08 - -$0.08-112.50%MissN/A11 up, 0 downNov 13, 2026
    Jun 30, 2026-$0.05-$0.09-$0.09 - -$0.09+44.44%BeatN/A11 up, 0 downAug 13, 2026
    Mar 31, 2026-$0.05-$0.19N/A+73.68%BeatN/A11 up, 0 downMay 15, 2026
    Dec 31, 2025-$0.01-$0.07-$0.07 - -$0.07+85.71%BeatN/A10 up, 0 downMar 18, 2026
    Sep 30, 2025-$0.13-$0.07-$0.07 - -$0.07-85.71%MissN/A10 up, 0 downNov 12, 2025
    Jun 30, 2025-$0.15-$0.12N/A-25.00%MissN/A10 up, 0 downAug 11, 2025
    Mar 31, 2025-$0.06-$0.11-$0.11 - -$0.11+45.45%BeatN/A10 up, 0 downMay 14, 2025
    Dec 31, 2024-$0.03-$0.12N/A+75.00%BeatN/AN/AN/AFeb 15, 2025
    Sep 30, 2024-$0.09-$0.12N/A+25.00%BeatN/AN/AN/ANov 14, 2024
    Jun 30, 2024-$0.11N/AN/AN/AN/AN/AN/AN/ASep 27, 2024
    Mar 31, 2024-$0.01N/AN/AN/AN/AN/AN/AN/AMay 14, 2024
    Dec 31, 2023-$0.03N/AN/AN/AN/AN/AN/AN/AFeb 14, 2024
    Sep 30, 2023-$1.78N/AN/AN/AN/AN/AN/AN/ASep 30, 2023
    Jun 30, 2023-$0.03N/AN/AN/AN/AN/AN/AN/AJun 30, 2023
    Mar 31, 2023-$0.03N/AN/AN/AN/AN/AN/AN/AJun 28, 2023
    Dec 31, 2022-$0.11N/AN/AN/AN/AN/AN/AN/AMar 29, 2023
    Sep 30, 2022-$0.06N/AN/AN/AN/AN/AN/AN/ANov 14, 2022
    Jun 30, 2022-$0.06N/AN/AN/AN/AN/AN/AN/ASep 28, 2022
    Mar 31, 2022-$0.02N/AN/AN/AN/AN/AN/AN/AJun 29, 2022
    Dec 31, 2021-$0.12N/AN/AN/AN/AN/AN/AN/AMar 30, 2022
    Sep 30, 2021-$0.02N/AN/AN/AN/AN/AN/AN/ANov 10, 2021
    Jun 30, 2021Not reportedN/AN/AN/ANot reportedN/AN/AN/ASep 28, 2021
    Last 22 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$0.35, after -$0.24 the year before. It was -$0.14 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$0.35N/A
    Dec 31, 2024-$0.24N/A
    Dec 31, 2023-$1.87N/A
    Dec 31, 2022-$0.25N/A
    Dec 31, 2021-$0.14N/A

    Frequently Asked Questions About ESLA

    When is Estrella Immunopharma's next earnings date?

    Estrella Immunopharma's next earnings report is expected for Mar 16, 2027.

    Did ESLA beat earnings estimates last quarter?

    No. Estrella Immunopharma reported EPS of -$0.17 for the quarter ended Sep 30, 2026, below the -$0.08 estimate by 112.50%.

    What EPS do analysts expect from ESLA next quarter?

    The consensus EPS estimate for Estrella Immunopharma for the quarter ending Dec 31, 2026 is -$0.07 from 3 analysts, with estimates from -$0.07 to -$0.07.

    How often does ESLA beat earnings estimates?

    Estrella Immunopharma beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +12.64%.